SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-19-044162
Filing Date
2019-09-10
Accepted
2019-09-10 17:06:22
Documents
1
Effectiveness Date
2019-09-10

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv529178_defa14a.htm DEFA14A 26662
  Complete submission text file 0001144204-19-044162.txt   27796
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-15070 | Film No.: 191085969
SIC: 2834 Pharmaceutical Preparations